(Q41108966)

English

Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys

scientific article published on 21 November 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

Oyekoya T Ayonrinde

object named as

Oyekoya T Ayonrinde

1

0 references

object named as

Trevor A Mori

4

0 references

object named as

Martha Hickey

7

0 references

Deborah Sloboda

8

object named as

Deborah M Sloboda

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Lawrence J Beilin

5

object named as

Lawrence J Beilin

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

author name string

Leon A Adams

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Dorota A Doherty

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Wendy H Oddy

6

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Roger Hart

10

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

publication date

21 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

980-987

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Prevalence of fatty liver in children and adolescents.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Polycystic ovarian syndrome--prognosis and outcomes

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Abnormal aminotransferase activity in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Insulin resistance in nonobese patients with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Interrelationships of serum androgens, omental adipose tissue metabolism, and nonalcoholic fatty liver disease in obese premenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Histopathology of pediatric nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Nonalcoholic fatty liver disease and polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: do androgens play a role?

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Establishing a standard definition for child overweight and obesity worldwide: international survey

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13241

21 January 2018

Identifiers

10.1111/JGH.13241

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

release_7gxshrs3dfcc3f4le2uhe7hmey

1 reference

https://api.fatcat.wiki/v0/release/7gxshrs3dfcc3f4le2uhe7hmey

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41108966&oldid=2094018111"